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Abstract
Background: Regulatory T-cells (Tregs), characterized as CD4+CD25hi T-cells expressing FOXP3, play a crucial role in
controlling healthy immune development during early immune maturation. Recently, FOXP3 demethylation was suggested
to be a novel marker for natural Tregs in adults. In cord blood, the role and function of Tregs and its demethylation is poorly
understood. We assessed FOXP3 demethylation in cord blood in relation to previously used Treg markers such as
CD4+CD25hi, FOXP3 mRNA, protein expression, and suppressive Treg function.
Methodology: Cord blood mononuclear cells (CBMC) were isolated from 70 healthy neonates, stimulated for 3 days with the
microbial stimulus lipid A (LpA), and allergen Dermatophagoides pteronyssinus (Derp1). Tregs (CD4+CD25hi, intracellular,
mRNA FOXP3 expression, isolated cells), DNA methylation of the FOXP3-locus and suppressive Treg function were assessed.
Principal Findings: Demethylation of FOXP3 in whole blood was specific for isolated CD4+CD25hi Tregs. Demethylation of
FOXP3 was positively correlated with unstimulated and LpA-stimulated FOXP3 mRNA-expression (p#0.05), and CD4+CD25hi
T-cells (p#0.03). Importantly, increased FOXP3 demethylation correlated with more efficient suppressive capacity of Tregs
(r = 0.72, p=0.005). Furthermore, FOXP3 demethylation was positively correlated with Th2 cytokines (IL-5, IL-13) following LpA-
stimulation (p=0.006/0.04), with Th2 and IL-17 following Derp1+LpA-stimulations (p#0.009), but not Th1 cytokines (IFN-c).
Conclusions: FOXP3 demethylation reliable quantifies Tregs in cord blood. FOXP3 demethylation corresponds well with the
suppressive potential of Tregs. The resulting strict correlation with functionally suppressive Tregs and the relative ease of
measurement render it into a valuable novel marker for large field studies assessing Tregs as qualitative marker indicative of
functional activity.
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Introduction
Regulatory T-cells (Tregs) are essential for the downregulation of T
cell responses to both foreign and self antigens and play an important
role in several immune-mediated diseases, such as allergic diseases
[1]. Various studies including ours suggested that Tregs may play a
crucial role in early allergy protection by keeping the immune system
in balance and counter-regulating potential default pathways [2–4].
The general picture of Treg development is that there are two
different sources of Treg, one is derived from the thymus (natural or
nTreg) and one develops in the periphery (induced or iTreg), which
acquire a Treg phenotype and function in the periphery [5].
In several human studies, Tregs were best characterized as
CD4+CD25hi T-cells expressing the forkhead box transcription
factor (FOXP3), which suppress T cell activation and regulate
various immune reactions in vitro and in vivo [6–8]. We and others
have demonstrated that Tregs were present and functional in cord
blood mononuclear cells [3–4,9], though less suppressive compared
to adult peripheral blood mononuclear cells (PBMC) [3].
The presence and function of Tregs in cord blood may be
evolutionary useful and essential to prevent immune dysregulation
resulting in either acute infections or chronic immune modulation
as suggested for chronic diseases such as allergies or autoimmune
disorders. For international multicenter population studies assessing
Tregs for example in the development of allergic diseases in early
childhood, it is critical to use a parameter for Tregs, which is specific
and at the same time feasible to assess in large field studies when
storage and transport conditions do not allow immediate assessment
of Tregs by flow cytometry. Thus, a marker specific for Tregs and
indirectly indicating effective function might provide means for
reaching an improved understanding of early immune regulation of
Tregs in the development of immune-mediated diseases.
FOXP3 has been shown to be the most specific marker for Tregs
representing a central control element for the development and
function of Tregs [10]. However, transient FOXP3 mRNA was also
observed in activated non-Tregs, most notably in conventional
CD4+ T-cells upon activation [11–12]. Thus, FOXP3 expression
does not allow the unambiguous characterization of Tregs in
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humans. One option would be to additionally assess amount and
functional capacities of Tregs by additional markers using flow
cytometry and functional suppression assays [4,13], however this is
generally not feasible in large field studies. Recently, Floess S et al.
described that demethylation of CpG motifs of FOXP3 was
displayed especially in natural Tregs, but not or incomplete in naı¨ve
CD252CD4+ T-cells or in vitro TGF-b-induced FOXP3+ Tregs
[14–15]. They detected that stable FOXP3 expression was found
only for cells displaying demethylation at a TSDR (Treg-specific
demethylated region) [16]. Thus, TSDR was suggested to be an
important methylation-sensitive element regulating FOXP3 gene
expression. Epigenetic imprinting in this region may be critical for
establishment of a stable Treg lineage. To date, TSDR demethyl-
ation has been proven to be specific for Tregs only in adults.
There are no markers reliably differentiating between natural
and induced Tregs in vivo. In contrast, it appears that all in vivo
Tregs (independent of their origin) express CD25 and Foxp3 and
they are demethylated in the TSDR. Since iTreg are not generally
expected to be present in cord blood, this tissue appears to be
uniquely suitable for the characterisation of natural, thymus
derived Tregs. Thus, demethylation of Tregs may be a very
reliable and specific marker useful and feasible to assess in large
field studies in cord blood, however not examined yet.
Therefore, we aimed to assess Treg demethylation as novel
marker in cord blood in relation to previously used Treg markers
such as CD4+CD25hi surface expression, FOXP3 mRNA and
protein expression, and evaluate Treg demethylation in relation to
the suppressive function of Tregs on effector cells.
Methods
Written informed consent was obtained from the mothers for
participation. Approval was obtained from the local human
research committee of the Bavarian Ethical Board, LMU Munich,
Germany.
Study populations
Fetal cord blood (n = 60) was obtained from a birth-cohort-
study, which was performed from July 2005 to September 2008 in
the outer Munich area in Germany. Pregnant mothers were
recruited in the last trimester of pregnancy. Inclusion criteria
comprised healthy neonates and mothers with uncomplicated
pregnancy. Exclusion criteria were preterm deliveries, multiple
gestation (twins, triplets), perinatal infections including fever
around birth, maternal intake of medication and maternal chronic
diseases. 59 samples were included with complete immunological
data. Additional donors (n = 5) were recruited for isolation
experiments by random selection procedure.
FOXP3-specific real-time PCR
Genomic DNA was isolated from EDTA-handled cord blood with
DNeasy Blood-Kit (Qiagen, Hilden, Germany). From 2ml EDTA-
blood, a recovery of 300–900 mg/ml DNA is sufficient for the 20ng of
DNA, which is required for methylation analysis. Real-time-PCR for
measurement of the FOXP3 Treg-specific demethylated region
(TSDR) was performed in 20ml using Roche LightCyclerH 480
Probes Master (Roche Diagnostics, Mannheim, Germany) contain-
ing 15pmol of methylation or non-methylation-specific forward and
reverse primers for TSDR, 5pmol hydrolysis probe, 200ng lambda-
DNA (New England Biolabs, Frankfurt, Germany) and 30ng
bisulfite-treated genomic DNA template or respective amount of
plasmid standard [16]. Each sample was analyzed in triplicate using
a Light-Cycler 480 System. Since Foxp3 is X-linked, in all male Treg
cells the one Foxp3 gene is totally demethylated. In females, having
two X-chromosomes, in Treg cells X-inactivation leads to complete
inactivation and methylation of the bar body and one out of the two
X-chromosomes in female Treg cells remains fully methylated. The
other ‘‘open’’ x-chromosome is demethylated in female Tregs. For
calculation of Treg ratios in a given cell sample, it is necessary to
multiply with a factor of 2 in order to determine the Treg number.
This has been done in all female samples.
Isolation and culture of CBMC
Cord blood mononuclear cells (CBMC) were isolated by
density-gradient centrifugation with Ficoll-Hypaque. CBMC were
stimulated with lipid A (LpA, 0.1mg/mL), phytohemagglutinin
(PHA, 5mg/mL), and in addition Dermatophagoides pteronyssinus
(Derp1, 30mg/mL) for 3 days as previously described [4] and
compared to unstimulated samples. Significant changes through
endotoxin were excluded by functional assays as previously
described [17]. Cytokines were measured in supernatants; cells
were collected for mRNA extraction or flow cytometry.
Real-time quantitative RT-PCR
Total RNA was isolated from CBMC with TRI Reagent, and
reverse transcribed to cDNA with reverse transcriptase (Invitro-
gen, Karlsruhe, Germany). Specific primer pairs for 18-S, FOXP3
were designed with Vector NTI advance10 (Invitrogen, Karlsruhe,
Germany) as described before [17]. Direct detection of the PCR
product was monitored by measuring the increase in fluorescence
caused by the binding of SYBR Green to dsDNA using iCycler
(BIORAD, Munich, Germany). The determined threshold cycle
(ct) is the number of PCR cycles required for the fluorescence
signal to exceed the detection threshold, which was set to the log-
linear range of the amplification curve. Lower delta CT represents
higher mRNA expression.
Flow cytometry
CBMC were analyzed using 3-color flow cytometry (FACScan,
Becton-Dickinson, Germany). For surface staining, 2ml anti-
human CD4-FITC, 1ml CD25-PC5 (Immunotech, Beckman
Coulter, Marseille, France), 1ml IgG1-FITC (Dako Cytomation,
Denmark), 0.5ml IgG2a PC5 (BD Pharmingen, Germany) was
added. For intracellular FOXP3 staining, 8 ml anti-human CD4-
FITC, 4ml anti-human CD25-PC5 antibodies (16106/100ml) were
used, cell permeabilization was performed, and 10ml FOXP3-PE/
corresponding isotype-control antibodies (Natutec eBioscience,
Munich, Germany) was added. Samples were measured with
FACScan (Becton Dickinson, Heidelberg, Germany). Data were
analyzed with CellQuest software (Becton Dickinson, Germany),
post acquisition analysis was performed with WinMDI 2.8
software (Becton Dickinson, Mountain View, CA, USA).
Isolation and suppressive function of Tregs
APCs were isolated after positive depletion of CD3+ cells
(CD3 isolation-kit, Miltenyi Biotec, Germany) and irradiated
(30 Gy, 3000 rad, 10 min). CD4+CD252 effector T-cells and
CD4+CD25+T-cells were isolated (two-step-procedure), using
depletion of non-CD4+cells, followed by positive selection of
CD4+CD25+T-cells (Miltenyi Biotec, Germany). CD4+CD252 T-
cells (26104/well), labelled with 5mM CFSE (Invitrogen, Germany)
were incubated for 3 days with irradiated CD3- cells (46104/well) in
coculture with/without CD4+CD25+T-cells (26104/well) with
0.8mg/ml PHA stimulation. Division and proliferation of
CD4+CD252 T-cells were assessed by flow cytometry or 3[H]-
thymidin incorporation, respectively. The suppressive capacity of
Tregs was defined as the following:
FOXP3-Demethylation-Cord Tregs
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(division or proliferation of effector T-cells without Tregs){(division or proliferation of effector T-cells with Tregs)
division or proliferation of effector T-cells without Tregs
FACS Sorting
CBMC were stained using the surface markers anti-human
CD4-FITC (40ml) and CD25-PC5 (20ml, Immunotech, Beck-
man Coulter, Marseille, France) per 16107 cells and sorted
by FACS (MoFlo XDP, Dako) in two subpopulations:
CD4+CD252 and CD4+CD25hi. DNA extraction was per-
formed with QIAamp DNA Micro-Kit (Qiagen, Hilden,
Germany) and FOXP3-methylation specific real-time PCR as
described above.
Cytokine measurements
The concentrations of cytokines in supernatants were measured
after 3 days of stimulation with the Human Cytokine Multiplex
Assay Kit according to the manufacturer’s instructions, Bio-Rad,
Munich, Germany). The limits of detection (pg/ml) were 1.8 (IL-
5), 2.1 (IL-13), 0.2 (IL-17) and 1.3 (IFN-c). Non-detectable
cytokine concentrations were assigned to a value of 0.01 for
inclusion into the analysis.
Statistical analysis
Data analysis was performed with SigmaStat3.5, SPSS14.0 and
SAS 9.2 (SAS-Institute, Inc. Chicago, Ill) software. Correlations
were analyzed using Pearson Product Moment Correlation or
Spearman Rank Order Correlation based on distribution of the
data. T-test was used for the comparison of group differences of
suppressive capacity of Tregs (%). Statistical significance was
defined by p,0.05.
Results
Specificity of FOXP3 demethylation for isolated Tregs in
cord blood
In FACS-sorted isolated CD4+CD252 T-cells and CD4+CD25hi
T-cells from cord blood, FOXP3 demethylation was hardly
detectable in CD4+CD252 cells and well detectable in a mean of
81% in the CD4+CD25high T cells (Fig. 1A,B). In parallel, Foxp3
protein was expressed intracellular in a mean of 90% for
CD4+CD25hi T-cells; one representative sample is shown in Fig. 1 C.
Demethylation of FOXP3 in whole blood was positively
correlated with unstimulated and LpA-activated FOXP3
mRNA expression in cord blood
FOXP3 mRNA expression is currently used in several studies
assessing Tregs, in particular in the context of microbial exposure
such as Lipid A, LpA (TLR4 stimulus). In Fig. 2, FOXP3 mRNA
expression is shown as delta ct values. A lower delta ct corresponds
to higher FOXP3 gene expression. FOXP3 mRNA expression in
unstimulated and LpA-stimulated cells was positively correlated
with demethylation (%) of FOXP3 in whole blood, though with
low correlation coefficient (r = 0.32, p = 0.02; r = 0.29, p = 0.05,
Fig. 2A/B). Assessing stimulation with the allergen house dust mite
Derp1 alone and a ‘‘natural environmental stimuli’’, such as a
combination of Derp1+LpA stimulation, FOXP3 mRNA expres-
sion showed no significant correlation with demethylation in whole
blood (%) of FOXP3 (data not shown).
Figure 1. FOXP3 demethylation in isolated CD4CD252 and CD4CD25hi cells. A/B. CD4CD252 and CD4CD25hi cells were isolated with Dako
MoFlow. DNA was extracted and demethylation (%) of FOXP3 was measured with real-time PCR. C. Intracellular FOXP3 protein was measured in
CD4CD25hi cells as described in methods. N = 5, mean 6 SEM were shown in B, one representative sample for A/C.
doi:10.1371/journal.pone.0013267.g001
FOXP3-Demethylation-Cord Tregs
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13267
Demethylation of FOXP3 was positively correlated with
the amount of unstimulated and LpA-activated
CD4+CD25hi T-cells in cord blood
Tregs are commonly characterized by expression of the surface
marker CD4+CD25hi. In this study, more than 98% of CD4+CD25hi
T-cells expressed FOXP3 protein in cord blood in non-sorted
cells (Fig. 3). The amount of unstimulated and LpA-stimulated
CD4+CD25hi T-cells was positively correlated with increased
FOXP3 demethylation (%) (Fig. 4A/B).
Demethylation of FOXP3 was positively correlated with
the suppressive capacity of Tregs in cord blood
As the amount of Tregs is not indicative of its functional regulation,
we additionally assessed the suppressive capacity of CD4+CD25+ T-
cells on the division and proliferation of CD4+CD252 T-effector cells
in a subgroup (n = 13). Cell division is a specific indicator of
differences in cell cyles and was measured with CFSE staining of
effector cells, while proliferation assessed overall capacity of effector
cell proliferation measured by 3 [H]-thymidin incorporation. The
suppressive capacity of cell division was positively correlated with
demethylation of FOXP3 (r = 0.72, p = 0.005, Fig. 5A), while the
suppressive capacity of Tregs on proliferation showed a trend with
demethylation (r = 0.4, p = 0.2, Fig. 5B, n = 13). In parallel, when
dividing FOXP3 demethylation according to the median (0.70%)
into groups with relatively higher or lower demethylation, the
suppressive capacity of Tregs on effector cells (division and
proliferation) was significantly more effective in the higher compared
to the lower group (p = 0.005, p = 0.03; Fig. 5C).
The relationship between demethylation of FOXP3 and
cytokine secretion in cord blood
As Tregs balance immune responses of different T cell lineages,
we assessed whether demethylation of FOXP3 had an impact on
effector cell responses such as Th1/Th2 and Th17 cytokine
secretion. Distribution of cytokine expression (in pg/ml, medi-
an625/75. perc) were as follows: IFN-g M 0,04 (0,01/1,03), LpA
50,35 (16,10/96,08), Derp1+LpA 70,49 (51,69/113,34); IL-5 M
0,01 (0,01/0,09); LpA 4,99 (IQR 2,17, 10,18), Derp1+LpA 7,86
Figure 2. Correlation between demethylation of FOXP3 and unstimulated and LpA-activated FOXP3 mRNA expression.
Demethylation (%) of FOXP3 in whole cord blood was measured with real-time PCR. FOXP3 mRNA expression was measured with real-time RT-
PCR in unstimulated (A) and LpA-stimulated CBMCs (B), which were shown as delta ct to 18S. Lower delta ct represents higher mRNA expression.
N = 48; correlation was analyzed with Pearsons correlation coefficient.
doi:10.1371/journal.pone.0013267.g002
Figure 3. Percentage of FOXP3+ T-cells in unstimulated CD4+CD25hi T-cells. Flow cytometry of unstimulated CD4+CD25+ cells as described
in methods. A. R2 = CD4+CD25hi T-cell gate. B. Out of CD4+CD25hi T-cells, 98.1% were FOXP3+ T-cells.
doi:10.1371/journal.pone.0013267.g003
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(3,55/17,68); IL-13 M 0,33 (0,06/0,76), LpA 3,23 (1,46/8,22),
D+L 6,16 (2,60/14,38) and IL-17 M 0,01 (0,01/0,43), LpA 1,43
(0,08/3,95), Derp1+LpA 2,82 (0,46/6,03). No significant correla-
tion was found between FOXP3 demethylation (%) with cytokines
before stimulation (Table 1). FOXP3 demethylation was positive-
ly, however not highly correlated with Th2 cytokines (IL-5 and IL-
13) following LpA-stimulation. Following Derp1+LpA stimulation
the correlation was stronger. Control Derp1 stimulation alone
showed no significant correlation. In addition, FOXP3 demeth-
ylation was correlated with IL-17 secretion following Derp1+LpA
stimulated (Table 1). There was no correlation with Th1 cytokines
(IFN-c, Table 1) and not with IL-10, IL-15 and TNF-a (not
shown). IL-2 was correlated with FOXP3 demethylation after
Derp1+LpA stimulation (r = 0.35, p = 0.05, n = 30).
Figure 4. Correlation between demethylation of FOXP3 and CD4+CD25hi T-cells (%). Demethylation (%) of FOXP3 was measured with real-
time PCR. CD4+CD25hi T-cells (% in lymphocytes) were measured with flow cytometry. A. Correlation between FOXP3 demethylation and
unstimulated CD4+CD25hi T-cells (%). B. Correlation between FOXP3 demethylation and LpA-activated CD4+CD25hi T-cells (%). N = 20/24; correlation
was analyzed with Pearsons correlation coefficient.
doi:10.1371/journal.pone.0013267.g004
Figure 5. Relationship between demethylation (%) of FOXP3 and suppressive capacity of Tregs. Demethylation (%) of FOXP3 was
measured with real-time PCR. A. The correlation of demethylation of FOXP3 and suppressive capacity of CD4+CD25+ T-cells on the division of CFSE-
labelled CD4+CD252 T effector cells. Assessment by flow cytometry. B. Correlation of demethylation of FOXP3 and suppressive capacity of
CD4+CD25+Tcells on the proliferation of CD4+CD252 T effector cells, measured with 3[H]-thymidin incorporation. C. The suppressive capacity of
Tregs was more effective in cord blood with higher FOXP3 demethylation (%) (.median of 0.81). A–B: n = 13/12; Pearsons correlation coefficient.
C: n = 13, t-test, data were shown as mean+-SEM.
doi:10.1371/journal.pone.0013267.g005
FOXP3-Demethylation-Cord Tregs
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Discussion
We assessed quantitative and qualitative markers for Tregs in
cord blood, including CD4+CD25hi T-cells, FOXP3 mRNA and
protein expression, isolated Tregs and the suppressive capacity of
Tregs in relation to demethylation of FOXP3 (%) as novel marker
in whole blood. Demethylation of FOXP3 was shown to be
specific for isolated CD4+CD25hi Tregs in cord blood. Demeth-
ylation of FOXP3 was positively correlated with unstimulated and
trendwise for LpA-activated CD4+CD25hi T-cells and at low levels
with FOXP3 mRNA expression. Additionally, FOXP3 demeth-
ylation was positively associated with the suppressive function of
Tregs on effector cell division.
Tregs are crucial T-cells in immune homeostasis, as they balance
the immune system to avoid immune-mediated diseases such as
allergies, asthma, autoimmune disorders, cancer, infection or graft-
versus-host diseases [18–20]. To date, multiple markers are used to
assess Tregs, including FOXP3, CD25hi, TGF-b, GITR, LAG3,
CTLA-4, CD69, CD44, CD127-/low and CD49d [21–22]. The
transcription factor FOXP3 is the most specific and widely used
molecular marker for identification and characterization of Tregs
[23]. Recently, a new marker for Tregs was described to be reliable
and objective for the identification and quantification of Tregs in
adults. Floess at al. showed that DNA demethylation at the FOXP3
locus (TSDR), both in mice and human adults, coincides with the
generation of stable Tregs [14–16].
FOXP3 demethylation may be a technically precise marker in
addition to currently assessed CD4+CD25hi T-cells measurements,
which is not completely standardized in particular under different
stimulation conditions in large population studies. Additionally,
human Tregs were shown to be a rapidly proliferating population
compared to naı¨ve or memory T-cells, but were short-lived and
underwent apoptosis at a far higher rate than naive or memory
cells. FOXP3 demethylation (%) may represent an intrinsically
more stable parameter for Tregs than mRNA expression or
protein synthesis, and can be accurately quantified [24–25].
However, all current data derive from murine studies or adults,
where immune maturation has taken place and Tregs are often
stimulated and have a different phenotype than early in life.
This study shows for the first time that early in life, namely in cord
blood, FOXP3 demethylation is very low in CD4+CD252 T cells
and high in CD4+CD25hi T-cells. Thus, from early in life, FOXP3
methylation seems to be a stable parameter for Treg assessment.
While in adults the signal derives from iTregs and nTregs, we can
claim that in cord blood it comes from nTregs only.
Additionally, FOXP3 demethylation was well correlated with
CD4+CD25hi expression but rather low with FOXP3 mRNA in
unstimulated conditions. The latter is not surprising as FOXP3
mRNA was assessed in bulk culture. Thus FOXP3 expression may
have also included expression in non-Tregs. When comparing
FOXP3 demethylation with LpA-stimulated FOXP3 mRNA
expression and CD4CD25+ high T-cells, correlations were low
or showed only a trend. The rationale to use LpA-stimulation was
to assess one ‘‘master stimulus’’ representing microbial exposure
(TLR4-stimulation) as ‘‘protective stimulus’’ against allergy
development. This shall provide the basis using FOXP3
methylation for in vivo microbial exposure in future field studies
assessing childhood pulmonary diseases such as allergic asthma.
The low correlations may be explained by a transient increase in
CD25 and Foxp3 expression following LpA stimulation, but no
change in demethylation, thus resulting in a weaker correlation.
Furthermore, assessing FOXP3 demethylation may indirectly
contribute to assess Tregs with functional suppression. It is
controversial whether all activated FOXP3+ T-cells have similar
suppressive capability [26–28]. Thus FOXP3 demethylation (%)
may contribute to distinguish natural Tregs (with complete
suppressive capacity) as compared to e.g. TGF-b induced
FOXP3-expressing Tregs (with incomplete suppressive capacity).
In the presented study, Treg function in cord blood – representing
nTregs only- was positively and strongly correlated with FOXP3
demethylation.
Thus, examining FOXP3 demethylation could potentially be
applied as an indirect surrogate marker of suppressive capacity
when more extensive evaluation can not be performed in large
population studies - either due to technical or logistic possibilities.
As regulatory T-cells are keeping immune responses in balance,
T-cell cytokines may be equally regulated by the demethylation
status of Tregs. In cord blood, FOXP3 demethylation was
positively correlated with Th2 cytokines (IL-5 and IL-13), however
at low levels. Following Derp1+LpA stimulation, besides Th2
cytokines, also IL-17 production, but not Th1 cytokines (IFN-c),
was positively correlated with FOXP3 demethylation. A correla-
tion of Th2-cells and IL-17 were described in two cord blood
populations before [4,17], however not related to Tregs. This
effect may be due to the immature nature of cord blood
representing a more Th2-shifted immune phenotype [29], and
thus not completely balanced at this stage. Previously, Th2
cytokines IL-4 and IL-6 have been shown to inhibit FOXP3
induction [30]; however IL-4 can on the other hand induce
proliferation of CD4CD25+ cells [31], thus a potential synergistic
mechanism is possible. While these results derived from murine
studies, cord blood is unique in terms of Treg regulations.
Although in humans Tregs can inhibit cytokine production of
effector cells in in vitro experiments [3], Tregs increased in parallel
with Th2 cytokines in autoimmune pancreato-cholangitis [32] and
the percentage of CD4+CD25int/CD4 T-cells was correlated
positively with IL-5, IL-10, and IL-13 in pollen-sensitized children
[33]. Th2 cytokines (IL-4, IL-13) can also induce FOXP3-
expressing CD4+CD25+ regulatory T-cells from healthy human
CD4+CD252 precursors [34]. Moreover, Tregs can differentiate
Table 1. Correlation between FOXP3 demethylation (%) and cytokine production in CBMC.
Cytokines Unstimulated LpA stimulated Derp1+LpA stimulated
r p r p r p
IFN-c 0.03 0.81 0.09 0.48 0.09 0.62
IL-5 0.07 0.57 0.37 0.006 0.55 0.002
IL-13 0.16 0.23 0.28 0.04 0.52 0.004
IL-17 0.07 0.59 0.09 0.52 0.48 0.009
n= 60. Data were analyzed with Spearman Rank Order Correlation. r = correlation coefficient.
doi:10.1371/journal.pone.0013267.t001
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to IL-17 producing cells under specific stimulation conditions [35–
36]. Thus, complex competitory mechanism among different Th
subgroups may be involved. Following diverse stimulations, the
interplay of Tregs and other Th lineages may be different, but this
clearly needs to be assessed in more detail early in life.
Overall, this novel method was shown to be quantitatively
comparable to previously used methods, but may be superior as an
adequate tool for routine applications in large international field
trials as it is technically less demanding and laborious than
previously used methods [25].
In summary, FOXP3 demethylation (%) was demonstrated to
be strongly correlated with Tregs early in life. FOXP3 demeth-
ylation was positively correlated with CD4+CD25hi T-cells and to
a lower degree with FOXP3 mRNA expression in cord blood.
Moreover, FOXP3 demethylation may represent an indirect
marker for efficient suppressive capacity of Tregs. Thus, FOXP3
demethylation may be used as a good quantitative and indirect
qualitative marker and valid method in multicenter field studies,
offering the possibility of an additional or potentially substitute
marker for assessment of Tregs.
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